On the filings, Johnson & Johnson (JNJ) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
Durable healthcare compounder at a fair price — the 90% EPS surge is mostly non-operating, so it's a steady hold, not a chase.
Cheap on adjusted earnings and free cash flow, but flat revenue and a self-flagged 2028 patent cliff cap upside — a value hold, not a grower.
| Metric | JNJ | PFE |
|---|---|---|
| Fundamentals score | 84 | 62 |
| Revenue growth (YoY) | +6.0% | -1.6% |
| Net income growth (YoY) | +90.6% | -3.2% |
| Net margin | 28.5% | 12.4% |
| Return on equity | 32.9% | 9.0% |
| ROIC (est.) | 13.9% | — |
| Liabilities / Equity | 1.44 | 1.40 |
| Piotroski F-score | 3 / 9 | 4 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 18, 2026, 7:23 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 19, 2026, 2:18 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.